Related Experiment Video
Updated: Jun 7, 2025

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Adjuvant strategies to tackle mcr-mediated polymyxin resistance
Madison R Nuske1,2, Junlang Zhong1,2, Renjie Huang3
1School of Chemistry, The University of Melbourne Parkville Victoria 3010 Australia ivanhoe.leung@unimelb.edu.au.
Abstract:
The emergence of the mobile colistin resistance (mcr) gene is a demonstrable threat contributing to the worldwide antibiotic resistance crisis. The gene is encoded on plasmids and can easily spread between different bacterial strains. mcr encodes a phosphoethanolamine (pEtN) transferase, which catalyses the transfer of the pEtN moiety from phosphatidylethanolamine to lipid A, the head group of lipopolysaccharides (LPS). This neutralises the overall negative charge of the LPS and prevents the binding of polymyxins to bacterial membranes. We believe that the development of polymyxin adjuvants could be a promising approach to prolong the use of this important class of last-resort antibiotics. This review discusses recent progress in the identification, design and development of adjuvants to restore polymyxin sensitivity in these resistant bacteria, and focuses on both MCR inhibitors as well as alternative approaches that modulate polymyxin resistance.
Insights
Mobile colistin resistance (mcr) genes on plasmids threaten antibiotic use. This review explores polymyxin adjuvants and MCR inhibitors to combat resistance and restore antibiotic effectiveness.
Area of Science:
- Microbiology
- Molecular Biology
- Pharmacology
Background:
- Mobile colistin resistance (mcr) genes are a growing global health threat, facilitating antibiotic resistance spread via plasmids.
- MCR enzymes modify lipopolysaccharides (LPS), preventing polymyxin binding and conferring resistance to these critical last-resort antibiotics.
Purpose of the Study:
- To review recent advancements in developing polymyxin adjuvants to overcome mcr-mediated resistance.
- To focus on strategies including MCR inhibitors and alternative approaches to restore polymyxin efficacy.
Main Methods:
- Literature review of recent research on mcr genes, polymyxin resistance mechanisms, and adjuvant development.
- Analysis of studies focusing on MCR inhibitors and other resistance modulation strategies.
Main Results:
- Polymyxin adjuvants show promise in restoring sensitivity to polymyxins in resistant bacteria.
- MCR inhibitors and alternative approaches are being actively investigated to combat resistance.
Conclusions:
- Developing polymyxin adjuvants is a crucial strategy to extend the utility of last-resort antibiotics.
- Continued research into MCR inhibitors and novel resistance modulation techniques is essential for addressing the antibiotic resistance crisis.
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antibiotic Selection
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Treatment Resistant Cancers
Cholinergic Antagonists: Pharmacokinetics

